Leu-M1 immunoreactivity and phaeochromocytoma.

The aim was to evaluate Leu-M1 immunoreactivity as a prognostic factor in phaeochromocytoma. Anti-Leu-M1 monoclonal antibodies were used to determine the Leu-M1 immunoreactivity in 17 histologically confirmed phaeochromocytomas from 15 patients, using an avidin-biotin technique. Ten patients had a s...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Pathol
Principais autores:	Masmiquel, L, Castro-Forns, M, de Torres, I, García, A, Vidal, M T, Simó, R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC499747/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9155703/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.50.2.168
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!